• HOME
  • ABOUT
    • TEAM
  • STRATEGY
  • PORTFOLIO
  • ADDRESS

Pix Vine Capital

PixVC provides early-stage venture capital to startups in the areas of Info-Tech, Med-Tech and Eco-Tech.

  • HOME
  • ABOUT
    • TEAM
  • STRATEGY
  • PORTFOLIO
  • ADDRESS

Proteona’s ESCAPE™ platform selected for SARS-CoV-2 vaccine characterization

May 15, 2020

 

Proteona has announced that it is beginning a partnership with Professor Nikolai Petrovsky from Flinders University to characterize the clinical response to a new SARS-CoV-2 vaccine.

More from SelectScience

Filed Under: Uncategorized

© 2025 Pix Vine Capital